Chimeric Antigen Receptor Structure and Manufacturing of Clinical Grade CAR Engineered Cells using Different Bioreactors.

Syed, Farhatullah; El Fakih, Riad; Alahmari, Ali D; Osman Ali, Ahmed S; Aljurf, Mahmoud

Syed, Farhatullah; El Fakih, Riad; Alahmari, Ali D; Osman Ali, Ahmed S; Aljurf, Mahmoud.

Afiliação

Syed F; Stem Cell & Tissue Re-engineering Program (Dpt)-R., King Faisal Specialist Hospital & Research Centre, Riyadh, 11211, Saudi Arabia.
El Fakih R; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, 11211, Saudi Arabia.
Alahmari AD; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, 11211, Saudi Arabia.
Osman Ali AS; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, 11211, Saudi Arabia.
Aljurf M; Oncology Centre, King Faisal Specialist Hospital & Research Centre, Riyadh, 11211, Saudi Arabia.

Hematol Oncol Stem Cell Ther ; 15(3): 137-152, 2022 Nov 07.

Article em En | MEDLINE | ID: mdl-36395497

Assuntos

Receptores de Antígenos Quiméricos; Humanos; Receptores de Antígenos Quiméricos/genética; Imunoterapia Adotiva/métodos; Linfócitos T; Terapia Baseada em Transplante de Células e Tecidos; Reatores Biológicos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google